Cutaneous Indeterminate Cell Histiocytosis of Donor Origin After Allogeneic Hematopoietic Stem-Cell Transplantation

Am J Dermatopathol. 2017 Sep;39(9):696-699. doi: 10.1097/DAD.0000000000000935.

Abstract

Allogeneic hematopoietic stem-cell transplantation and solid-organ transplantation are associated with an increased risk of secondary neoplasms. Indeterminate cell histiocytosis (ICH) is a rare disease composed of so-called indeterminate cells, an alleged cutaneous dendritic cell subset displaying histological and some ultrastructural and immunophenotypic features of Langerhans cells but lacking Birbeck granules. We report a case of cutaneous ICH occurring after allogeneic hematopoietic stem-cell transplantation for a myelodysplastic syndrome in a 56-year-old man. Microsatellite analysis demonstrated that the neoplastic cells were derived from the donor's hematopoietic system. This case broadens the spectrum of complications after stem-cell transplantation and demonstrates that cutaneous ICH in the setting of myelodysplastic syndromes may have a nonrelated origin to dysplastic myeloid cells.

Publication types

  • Case Reports

MeSH terms

  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Histiocytosis / etiology*
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / surgery
  • Skin Diseases / etiology*